Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Leukemia ; 20(4): 715-23, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16453006

ABSTRACT

The processes mediating genomic instability and clonal evolution are obscure in multiple myeloma (MM). Acquisition of new chromosomal translocations into the switch region of the immunoglobulin heavy chain (IgH) gene (chromosome 14q32) in MM, often heralds transformation to more aggressive disease. Since the combined effects of CD40 plus interleukin-4 (IL-4) mediate IgH isotype class switch recombination (CSR), and this process involves DNA double strand break repair (DSBR), we hypothesized that CD40 and/or IL-4 activation of MM cells could induce abnormal DNA DSBR and lead to genomic instability and clonal evolution. In this study, we show that MM cell lines that are optimally triggered via CD40 and/or IL-4 demonstrate abnormal decoupling of IL-4 signal transduction from CD40. Specifically, CD40 alone was sufficient to trigger maximal growth of tumor cells. We further demonstrate that CD40 triggering induced both DNA DSBs as well as newly acquired karyotypic abnormalities in MM cell lines. Importantly, these observations were accompanied by induction of activation induced cytidine deaminase expression, but not gross apoptosis. These data support the role of abnormal CD40 signal transduction in mediating genomic instability, suggesting a role for the CD40 pathway and intermediates in myelomagenesis and clonal evolution in vivo.


Subject(s)
CD40 Antigens/immunology , CD40 Ligand/pharmacology , Genomic Instability , Immunoglobulin Heavy Chains/immunology , Interleukin-4/immunology , Multiple Myeloma/genetics , Cell Line, Tumor , Cell Proliferation/drug effects , Cells, Cultured , Chromosome Aberrations , Cytidine Deaminase/biosynthesis , Cytidine Deaminase/drug effects , DNA/biosynthesis , DNA/drug effects , Humans , Immunoglobulin Heavy Chains/drug effects , Immunoglobulin Heavy Chains/genetics , Interleukin-4/pharmacology , Multiple Myeloma/metabolism , Signal Transduction/drug effects , Signal Transduction/immunology , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL